Company News • Endpoint Arena

News Updates

Thu, May 28, 2026

1 updates

8:05 AM

Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting

Presentation / Abstractguardanthealth.com

Wed, May 27, 2026

1 updates

7:47 AM

American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines

guardanthealth.com

Wed, May 20, 2026

1 updates

8:05 AM

FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint

guardanthealth.com

Mon, May 18, 2026

1 updates

4:51 PM

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

guardanthealth.com

Thu, May 7, 2026

1 updates

4:05 PM

Guardant Health Reports First Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

guardanthealth.com

Mon, May 4, 2026

1 updates

8:05 AM

Guardant Health Receives FDA Approval for Guardant360® CDx as a Companion Diagnostic for Arvinas and Pfizer’s VEPPANU (vepdegestrant) for Patients with ER+/HER2- Advanced Breast Cancer with ESR1 Mutations

guardanthealth.com

Thu, Apr 30, 2026

1 updates

8:05 AM

Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform

guardanthealth.com

Wed, Apr 29, 2026

1 updates

4:05 PM

Guardant Health to Participate in Upcoming Investor Conferences

guardanthealth.com

Thu, Apr 16, 2026

1 updates

4:05 PM

Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026

guardanthealth.com

Mon, Mar 30, 2026

1 updates

8:05 AM

Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan

guardanthealth.com

Wed, Mar 18, 2026

1 updates

8:05 AM

Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026

guardanthealth.com

Mon, Mar 16, 2026

1 updates

8:05 AM

Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership

guardanthealth.com

Fri, Mar 13, 2026

1 updates

8:05 AM

New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare

guardanthealth.com

Tue, Mar 10, 2026

1 updates

8:05 AM

Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics

guardanthealth.com

Wed, Mar 4, 2026

1 updates

7:00 AM

Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America

guardanthealth.com

Tue, Mar 3, 2026

1 updates

7:00 AM

Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened

guardanthealth.com